HEADER APOPTOSIS 10-APR-09 3H11 TITLE ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASP8 AND FADD-LIKE APOPTOSIS REGULATOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CASPASE-8; COMPND 7 CHAIN: B; COMPND 8 EC: 3.4.22.61; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: IETD ALDEHYDE INHIBITOR; COMPND 13 CHAIN: C; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CFLAR, CASH, CASP8AP1, CLARP, MRIT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP8, MCH5; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES KEYWDS CELL DEATH, APOPTOSIS, CASPASE, ALTERNATIVE SPLICING, HOST-VIRUS KEYWDS 2 INTERACTION, POLYMORPHISM, CYTOPLASM, DISEASE MUTATION, HYDROLASE, KEYWDS 3 PHOSPHOPROTEIN, PROTEASE, THIOL PROTEASE, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR P.D.JEFFREY,J.W.YU,Y.SHI REVDAT 5 13-OCT-21 3H11 1 SEQADV LINK REVDAT 4 24-NOV-09 3H11 1 AUTHOR REVDAT 3 02-JUN-09 3H11 1 JRNL REVDAT 2 19-MAY-09 3H11 1 JRNL REVDAT 1 28-APR-09 3H11 0 JRNL AUTH J.W.YU,P.D.JEFFREY,Y.SHI JRNL TITL MECHANISM OF PROCASPASE-8 ACTIVATION BY C-FLIPL. JRNL REF PROC.NATL.ACAD.SCI.USA V. 106 8169 2009 JRNL REFN ISSN 0027-8424 JRNL PMID 19416807 JRNL DOI 10.1073/PNAS.0812453106 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1868369.990 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 37271 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1844 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5830 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 290 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3595 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.37000 REMARK 3 B22 (A**2) : 8.77000 REMARK 3 B33 (A**2) : -13.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 54.94 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : MODIFIERS.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3H11 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052556. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : SI(111) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37398 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07300 REMARK 200 FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46800 REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9 M SODIUM DIHYDROGEN PHOSPHATE, 0.8 REMARK 280 M DIPOTASSIUM HYDROGEN PHOSPHATE, 0.1 M N-CYCLOHEXYL-3- REMARK 280 AMINOPROPANESULFONIC ACID (CAPS), 0.2 M LITHIUM SULFATE, PH 10.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.49500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.09500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.34000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.09500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.49500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.34000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE SMALL PEPTIDE (CHAIN C) IS A REMARK 300 COVALENT INHIBITOR, AND THE NATIVE STATE OF THE PROTEINS (CHAIN A REMARK 300 AND CHAIN B) IS DIMERIC. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 209 REMARK 465 GLU A 210 REMARK 465 GLN A 211 REMARK 465 ARG A 212 REMARK 465 LEU A 213 REMARK 465 LYS A 214 REMARK 465 GLU A 215 REMARK 465 GLN A 216 REMARK 465 LEU A 217 REMARK 465 GLY A 218 REMARK 465 ALA A 219 REMARK 465 GLN A 220 REMARK 465 GLN A 221 REMARK 465 GLU A 222 REMARK 465 PRO A 223 REMARK 465 VAL A 224 REMARK 465 LYS A 225 REMARK 465 LYS A 226 REMARK 465 SER A 227 REMARK 465 ILE A 228 REMARK 465 GLN A 229 REMARK 465 GLU A 230 REMARK 465 SER A 231 REMARK 465 GLU A 232 REMARK 465 ALA A 233 REMARK 465 PHE A 234 REMARK 465 LEU A 235 REMARK 465 PRO A 236 REMARK 465 SER A 363 REMARK 465 GLU A 364 REMARK 465 GLY A 365 REMARK 465 GLN A 366 REMARK 465 LEU A 367 REMARK 465 GLU A 368 REMARK 465 ASN A 369 REMARK 465 SER A 370 REMARK 465 SER A 371 REMARK 465 LEU A 372 REMARK 465 LEU A 373 REMARK 465 GLU A 374 REMARK 465 VAL A 375 REMARK 465 ASP A 376 REMARK 465 GLY A 377 REMARK 465 PRO A 378 REMARK 465 ALA A 379 REMARK 465 MET A 380 REMARK 465 LYS A 381 REMARK 465 ASN A 382 REMARK 465 VAL A 383 REMARK 465 GLU A 384 REMARK 465 PHE A 385 REMARK 465 LYS A 386 REMARK 465 ALA A 387 REMARK 465 GLN A 388 REMARK 465 LYS A 389 REMARK 465 ARG A 390 REMARK 465 GLY A 391 REMARK 465 LEU A 392 REMARK 465 CYS A 393 REMARK 465 THR A 394 REMARK 465 SER B 202 REMARK 465 GLU B 203 REMARK 465 SER B 204 REMARK 465 GLN B 205 REMARK 465 THR B 206 REMARK 465 LEU B 207 REMARK 465 LYS B 352 REMARK 465 GLY B 353 REMARK 465 ILE B 354 REMARK 465 PRO B 355 REMARK 465 VAL B 356 REMARK 465 GLU B 357 REMARK 465 THR B 358 REMARK 465 ALA B 359 REMARK 465 SER B 360 REMARK 465 GLU B 361 REMARK 465 GLU B 362 REMARK 465 GLN B 363 REMARK 465 PRO B 364 REMARK 465 TYR B 365 REMARK 465 LEU B 366 REMARK 465 GLU B 367 REMARK 465 MET B 368 REMARK 465 ALA B 369 REMARK 465 LEU B 370 REMARK 465 SER B 371 REMARK 465 SER B 372 REMARK 465 PRO B 373 REMARK 465 ASP B 439 REMARK 465 ASP B 440 REMARK 465 LYS B 441 REMARK 465 LYS B 442 REMARK 465 ASN B 443 REMARK 465 MET B 444 REMARK 465 VAL B 465 REMARK 465 GLU B 466 REMARK 465 HIS B 467 REMARK 465 HIS B 468 REMARK 465 HIS B 469 REMARK 465 HIS B 470 REMARK 465 HIS B 471 REMARK 465 HIS B 472 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 SER A 416 OG REMARK 470 HIS A 417 CG ND1 CD2 CE1 NE2 REMARK 470 SER A 418 OG REMARK 470 SER A 419 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 237 C - N - CA ANGL. DEV. = 11.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 283 57.74 35.98 REMARK 500 GLN A 319 41.38 -141.23 REMARK 500 ALA B 232 8.13 -63.74 REMARK 500 ARG B 233 -13.09 -141.91 REMARK 500 LYS B 235 -6.59 -140.20 REMARK 500 PRO B 237 -34.56 -28.03 REMARK 500 ASP B 271 86.29 42.91 REMARK 500 SER B 301 -175.71 -171.52 REMARK 500 LYS B 305 109.64 -41.09 REMARK 500 TYR B 377 -37.44 63.27 REMARK 500 ASN B 393 -11.96 77.32 REMARK 500 ILE C 701 109.38 -55.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR B 284 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3H13 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THIS SEQUENCE DISCREPANCY MAY BE DUE TO REMARK 999 VARIATIONS AMONG DIFFERENT CONSTRUCTS IN THE DATABASES. RESIDUE 369 REMARK 999 IS ASN IN GENBANK ENTRY CAA74366.1 DBREF 3H11 A 209 480 UNP O15519 CFLAR_HUMAN 209 480 DBREF 3H11 B 202 464 UNP Q14790 CASP8_HUMAN 217 479 DBREF 3H11 C 700 704 PDB 3H11 3H11 700 704 SEQADV 3H11 ASN A 369 UNP O15519 ASP 369 SEE REMARK 999 SEQADV 3H11 ALA B 359 UNP Q14790 ASP 374 ENGINEERED MUTATION SEQADV 3H11 ALA B 369 UNP Q14790 ASP 384 ENGINEERED MUTATION SEQADV 3H11 VAL B 465 UNP Q14790 EXPRESSION TAG SEQADV 3H11 GLU B 466 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 467 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 468 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 469 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 470 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 471 UNP Q14790 EXPRESSION TAG SEQADV 3H11 HIS B 472 UNP Q14790 EXPRESSION TAG SEQRES 1 A 272 LYS GLU GLN ARG LEU LYS GLU GLN LEU GLY ALA GLN GLN SEQRES 2 A 272 GLU PRO VAL LYS LYS SER ILE GLN GLU SER GLU ALA PHE SEQRES 3 A 272 LEU PRO GLN SER ILE PRO GLU GLU ARG TYR LYS MET LYS SEQRES 4 A 272 SER LYS PRO LEU GLY ILE CYS LEU ILE ILE ASP CYS ILE SEQRES 5 A 272 GLY ASN GLU THR GLU LEU LEU ARG ASP THR PHE THR SER SEQRES 6 A 272 LEU GLY TYR GLU VAL GLN LYS PHE LEU HIS LEU SER MET SEQRES 7 A 272 HIS GLY ILE SER GLN ILE LEU GLY GLN PHE ALA CYS MET SEQRES 8 A 272 PRO GLU HIS ARG ASP TYR ASP SER PHE VAL CYS VAL LEU SEQRES 9 A 272 VAL SER ARG GLY GLY SER GLN SER VAL TYR GLY VAL ASP SEQRES 10 A 272 GLN THR HIS SER GLY LEU PRO LEU HIS HIS ILE ARG ARG SEQRES 11 A 272 MET PHE MET GLY ASP SER CYS PRO TYR LEU ALA GLY LYS SEQRES 12 A 272 PRO LYS MET PHE PHE ILE GLN ASN TYR VAL VAL SER GLU SEQRES 13 A 272 GLY GLN LEU GLU ASN SER SER LEU LEU GLU VAL ASP GLY SEQRES 14 A 272 PRO ALA MET LYS ASN VAL GLU PHE LYS ALA GLN LYS ARG SEQRES 15 A 272 GLY LEU CYS THR VAL HIS ARG GLU ALA ASP PHE PHE TRP SEQRES 16 A 272 SER LEU CYS THR ALA ASP MET SER LEU LEU GLU GLN SER SEQRES 17 A 272 HIS SER SER PRO SER LEU TYR LEU GLN CYS LEU SER GLN SEQRES 18 A 272 LYS LEU ARG GLN GLU ARG LYS ARG PRO LEU LEU ASP LEU SEQRES 19 A 272 HIS ILE GLU LEU ASN GLY TYR MET TYR ASP TRP ASN SER SEQRES 20 A 272 ARG VAL SER ALA LYS GLU LYS TYR TYR VAL TRP LEU GLN SEQRES 21 A 272 HIS THR LEU ARG LYS LYS LEU ILE LEU SER TYR THR SEQRES 1 B 271 SER GLU SER GLN THR LEU ASP LYS VAL TYR GLN MET LYS SEQRES 2 B 271 SER LYS PRO ARG GLY TYR CYS LEU ILE ILE ASN ASN HIS SEQRES 3 B 271 ASN PHE ALA LYS ALA ARG GLU LYS VAL PRO LYS LEU HIS SEQRES 4 B 271 SER ILE ARG ASP ARG ASN GLY THR HIS LEU ASP ALA GLY SEQRES 5 B 271 ALA LEU THR THR THR PHE GLU GLU LEU HIS PHE GLU ILE SEQRES 6 B 271 LYS PRO HIS ASP ASP CYS THR VAL GLU GLN ILE TYR GLU SEQRES 7 B 271 ILE LEU LYS ILE TYR GLN LEU MET ASP HIS SER ASN MET SEQRES 8 B 271 ASP CYS PHE ILE CYS CYS ILE LEU SER HIS GLY ASP LYS SEQRES 9 B 271 GLY ILE ILE TYR GLY THR ASP GLY GLN GLU ALA PRO ILE SEQRES 10 B 271 TYR GLU LEU THR SER GLN PHE THR GLY LEU LYS CYS PRO SEQRES 11 B 271 SER LEU ALA GLY LYS PRO LYS VAL PHE PHE ILE GLN ALA SEQRES 12 B 271 CYS GLN GLY ASP ASN TYR GLN LYS GLY ILE PRO VAL GLU SEQRES 13 B 271 THR ALA SER GLU GLU GLN PRO TYR LEU GLU MET ALA LEU SEQRES 14 B 271 SER SER PRO GLN THR ARG TYR ILE PRO ASP GLU ALA ASP SEQRES 15 B 271 PHE LEU LEU GLY MET ALA THR VAL ASN ASN CYS VAL SER SEQRES 16 B 271 TYR ARG ASN PRO ALA GLU GLY THR TRP TYR ILE GLN SER SEQRES 17 B 271 LEU CYS GLN SER LEU ARG GLU ARG CYS PRO ARG GLY ASP SEQRES 18 B 271 ASP ILE LEU THR ILE LEU THR GLU VAL ASN TYR GLU VAL SEQRES 19 B 271 SER ASN LYS ASP ASP LYS LYS ASN MET GLY LYS GLN MET SEQRES 20 B 271 PRO GLN PRO THR PHE THR LEU ARG LYS LYS LEU VAL PHE SEQRES 21 B 271 PRO SER ASP VAL GLU HIS HIS HIS HIS HIS HIS SEQRES 1 C 5 ALA ILE GLU THR ASA MODRES 3H11 ASA C 704 ASP ASPARTIC ALDEHYDE HET ASA C 704 8 HETNAM ASA ASPARTIC ALDEHYDE FORMUL 3 ASA C4 H7 N O3 FORMUL 4 HOH *123(H2 O) HELIX 1 1 GLU A 265 GLY A 275 1 11 HELIX 2 2 SER A 285 CYS A 298 1 14 HELIX 3 3 MET A 299 TYR A 305 5 7 HELIX 4 4 LEU A 333 MET A 341 1 9 HELIX 5 5 CYS A 345 ALA A 349 5 5 HELIX 6 6 SER A 411 LEU A 413 5 3 HELIX 7 7 SER A 421 GLU A 434 1 14 HELIX 8 8 PRO A 438 SER A 455 1 18 HELIX 9 9 ARG A 456 VAL A 457 5 2 HELIX 10 10 SER A 458 GLU A 461 5 4 HELIX 11 11 ALA B 230 LYS B 235 1 6 HELIX 12 12 VAL B 236 HIS B 240 5 5 HELIX 13 13 GLY B 247 LEU B 262 1 16 HELIX 14 14 THR B 273 MET B 287 1 15 HELIX 15 15 ILE B 318 SER B 323 1 6 HELIX 16 16 GLN B 324 THR B 326 5 3 HELIX 17 17 CYS B 330 ALA B 334 5 5 HELIX 18 18 TRP B 405 CYS B 418 1 14 HELIX 19 19 PRO B 419 GLY B 421 5 3 HELIX 20 20 ASP B 423 ASN B 437 1 15 SHEET 1 A 5 TYR A 276 LEU A 282 0 SHEET 2 A 5 GLY A 252 ASP A 258 1 N CYS A 254 O GLU A 277 SHEET 3 A 5 SER A 307 GLY A 317 1 O VAL A 309 N LEU A 255 SHEET 4 A 5 SER A 320 VAL A 321 -1 O SER A 320 N GLY A 317 SHEET 5 A 5 LEU A 331 PRO A 332 -1 O LEU A 331 N VAL A 321 SHEET 1 B12 TYR A 276 LEU A 282 0 SHEET 2 B12 GLY A 252 ASP A 258 1 N CYS A 254 O GLU A 277 SHEET 3 B12 SER A 307 GLY A 317 1 O VAL A 309 N LEU A 255 SHEET 4 B12 LYS A 353 VAL A 361 1 O MET A 354 N PHE A 308 SHEET 5 B12 PHE A 401 ASP A 409 1 O CYS A 406 N ASN A 359 SHEET 6 B12 TYR A 463 HIS A 469 -1 O GLN A 468 N TRP A 403 SHEET 7 B12 GLN B 450 PHE B 453 -1 O PHE B 453 N LEU A 467 SHEET 8 B12 PHE B 384 MET B 388 -1 N LEU B 386 O THR B 452 SHEET 9 B12 LYS B 338 GLN B 343 1 N PHE B 340 O GLY B 387 SHEET 10 B12 PHE B 295 LEU B 300 1 N PHE B 295 O VAL B 339 SHEET 11 B12 TYR B 220 ASN B 225 1 N LEU B 222 O CYS B 298 SHEET 12 B12 GLU B 265 ASP B 270 1 O HIS B 269 N ASN B 225 SHEET 1 C 3 GLY B 303 ASP B 304 0 SHEET 2 C 3 ILE B 307 TYR B 309 -1 O ILE B 307 N ASP B 304 SHEET 3 C 3 GLU B 315 PRO B 317 -1 O ALA B 316 N ILE B 308 SHEET 1 D 3 GLY B 403 THR B 404 0 SHEET 2 D 3 TYR B 397 ASN B 399 -1 N ASN B 399 O GLY B 403 SHEET 3 D 3 GLU C 702 THR C 703 -1 O GLU C 702 N ARG B 398 LINK C THR C 703 N ASA C 704 1555 1555 1.33 CISPEP 1 ILE A 239 PRO A 240 0 -0.34 CISPEP 2 LYS A 249 PRO A 250 0 0.34 CISPEP 3 LYS B 216 PRO B 217 0 -0.01 CRYST1 52.990 76.680 114.190 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018871 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008757 0.00000 MASTER 419 0 1 20 23 0 0 6 0 0 0 43 END